Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - pralsetinib - capsule - pralsetinib 100.0mg

Canada - English - Health Canada

hoffmann-la roche limited - pralsetinib - capsule - 100mg - pralsetinib 100mg - antineoplastic agents

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - pralsetinib - hard capsule - pralsetinib 100 mg - pralsetinib - - gavreto is indicated for the treatment of adult patients with metastatic ret fusion-positive non-small cell lung cancer (nsclc).- gavreto is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret-mutant medullary thyroid cancer (mtc) who require systemic therapy.- gavreto is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).